摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[7-(5,5-Diethyl-8-hydroxyoctoxy)-3,3-diethylheptyl] dihydrogen phosphate

中文名称
——
中文别名
——
英文名称
[7-(5,5-Diethyl-8-hydroxyoctoxy)-3,3-diethylheptyl] dihydrogen phosphate
英文别名
——
[7-(5,5-Diethyl-8-hydroxyoctoxy)-3,3-diethylheptyl] dihydrogen phosphate化学式
CAS
——
化学式
C23H49O6P
mdl
——
分子量
452.6
InChiKey
SXFXZHIZBZJXCB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    30
  • 可旋转键数:
    21
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    96.2
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • [EN] ETHER COMPOUNDS, COMPOSITIONS, AND USES THEREOF<br/>[FR] COMPOSES D'ETHER, COMPOSITIONS ET LEURS UTILISATIONS
    申请人:ESPERION THERAPEUTICS INC
    公开号:WO2000059855A1
    公开(公告)日:2000-10-12
    The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
    本发明涉及新型醚化合物、包含醚化合物的组合物及其用于治疗和预防心血管疾病、血脂异常、蛋白异常和葡萄糖代谢障碍的方法,包括给予含有醚化合物的组合物。本发明的化合物、组合物和方法还可用于治疗和预防阿尔茨海默病、X综合征、过氧化物酶体增殖物激活受体相关疾病、败血症、血栓性疾病、肥胖症、胰腺炎、高血压、肾脏疾病、癌症、炎症和阳痿。在某些实施例中,本发明的化合物、组合物和方法与其他治疗药物(如降胆固醇和降血糖药物)的联合治疗也是有用的。
  • Ether compounds, compositions, and uses thereof
    申请人:Esperion Therapeutics, Inc.
    公开号:EP1862444A2
    公开(公告)日:2007-12-05
    The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicaemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycaemic agents.
    本发明涉及新型醚类化合物、包含醚类化合物的组合物,以及用于治疗和预防心血管疾病、血脂异常、蛋白异常和糖代谢紊乱的方法,其中包含施用一种包含醚类化合物的组合物。本发明的化合物、组合物和方法还可用于治疗和预防阿尔茨海默病、X综合征、过氧化物酶体增殖物激活受体相关疾病、败血症、血栓性疾病、肥胖症、胰腺炎、高血压、肾病、癌症、炎症和阳痿。在某些实施方案中,本发明的化合物、组合物和方法可与其他治疗药物(如降胆固醇药和降血糖药)联合使用。
  • Ether compounds
    申请人:Esperion Therapeutics, Inc.
    公开号:US20030065195A1
    公开(公告)日:2003-04-03
    The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
    本发明涉及新型醚类化合物、包含醚类化合物的组合物,以及用于治疗和预防心血管疾病、血脂异常、蛋白异常和葡萄糖代谢紊乱的方法,其中包含施用一种包含醚类化合物的组合物。本发明的化合物、组合物和方法还可用于治疗和预防阿尔茨海默病、X综合征、过氧化物酶体激活受体相关疾病、败血症、血栓性疾病、肥胖症、胰腺炎、高血压、肾病、癌症、炎症和阳痿。在某些实施方案中,本发明的化合物、组合物和方法可与其他治疗药物(如降胆固醇药和降血糖药)联合使用。
  • Methods for synthesizing ether compounds and intermediates therefor
    申请人:Esperion Therapeutics, Inc.
    公开号:US20030125559A1
    公开(公告)日:2003-07-03
    The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
    本发明涉及新型醚类化合物、包含醚类化合物的组合物,以及用于治疗和预防心血管疾病、血脂异常、蛋白异常和葡萄糖代谢紊乱的方法,其中包含施用一种包含醚类化合物的组合物。本发明的化合物、组合物和方法还可用于治疗和预防阿尔茨海默病、X综合征、过氧化物酶体激活受体相关疾病、败血症、血栓性疾病、肥胖症、胰腺炎、高血压、肾病、癌症、炎症和阳痿。在某些实施方案中,本发明的化合物、组合物和方法可与其他治疗药物(如降胆固醇药和降血糖药)联合使用。
  • Compositions comprising ether compounds and pharmaceutical uses therefor
    申请人:Esperion Therapeutics, Inc.
    公开号:US20030149094A1
    公开(公告)日:2003-08-07
    The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
    本发明涉及新型醚类化合物、包含醚类化合物的组合物,以及用于治疗和预防心血管疾病、血脂异常、蛋白异常和葡萄糖代谢紊乱的方法,其中包含施用一种包含醚类化合物的组合物。本发明的化合物、组合物和方法还可用于治疗和预防阿尔茨海默病、X综合征、过氧化物酶体激活受体相关疾病、败血症、血栓性疾病、肥胖症、胰腺炎、高血压、肾病、癌症、炎症和阳痿。在某些实施方案中,本发明的化合物、组合物和方法可与其他治疗药物(如降胆固醇药和降血糖药)联合使用。
查看更多

同类化合物

(11bR,11''bR)-2,2''-[氧双(亚甲基)]双[4-羟基-4,4''-二氧化物-二萘并[2,1-d:1'',2''-f][1,3,2]二氧磷杂七环 (11aR)-10,11,12,13-四氢-5-羟基-3,7-二-1-萘-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂磷杂八环 鲸蜡基磷酸-鲸蜡基磷酸二乙醇胺 非对称二乙基二(二甲基胺基)焦磷酸酯 雷公藤甲素O-甲基磷酸酯二苄酯 阿扎替派 间苯二酚双[二(2,6-二甲基苯基)磷酸酯] 锌四戊基二(磷酸酯) 银(1+)二苄基磷酸酯 铵4-(2-甲基-2-丁炔基)苯基4-(2-甲基-2-丙基)苯基磷酸酯 铵2-乙基己基磷酸氢酯 铵2,3-二溴丙基磷酸酯 钾二己基磷酸酯 钾二十烷基磷酸酯 钾二乙基磷酸酯 钾[5,7,7-三甲基-2-(1,3,3-三甲基丁基)辛基]磷酸酯 钾2-己基癸基磷酸酯 钴(2+)十三烷基磷酸酯 钡4,4-二乙氧基-2,3-二羟基丁基磷酸酯 钠辛基氢磷酸酯 钠癸基氢磷酸酯 钠异丁基氢磷酸酯 钠二苄基磷酸酯 钠二(2-丁氧乙基)磷酸酯 钠O,O-二乙基磷酰蔷薇l烯酸酯 钠4-氨基苯基氢磷酸酯水合物(1:1:1) 钠3,6,9,12,15-五氧杂二十八碳-1-基氢磷酸酯 钠2-乙氧基乙基磷酸酯 钠2,3-二溴丙基磷酸酯 钙敌畏 钙二钠氟-二氧代-氧代膦烷碳酸盐 钙3,9-二氧代-2,4,8,10-四氧杂-3lambda5,9lambda5-二磷杂螺[5.5]十一烷3,9-二氧化物 野尻霉素6-磷酸酯 酚酞单磷酸酯 酚酞单磷酸环己胺盐 酚酞二磷酸四钠盐 酚酞二磷酸四钠 辛基磷酸酯 辛基二氯膦酸酯 辛基二氯丙基磷酸酯 辛基二丙基磷酸酯 赤藓糖醇4-磷酸酯 螺[环丙烷-1,9-四环[3.3.1.02,4.06,8]壬烷],2-甲基-,(1-alpha-,2-ba-,4-ba-,5-alpha-,6-ba-,8-ba-)-(9CI) 蚜螨特 莽草酸-3-磷酸酯三钠盐 莽草酸-3-磷酸酯 苯酚,2,4-二硝基-,磷酸(酯)氢 苯氨基磷酸二乙酯 苯基二(2,4,6-三甲基苯基)磷酸酯 苯丁酰胺,N-(5-溴-2-吡啶基)-2,4-二甲基-α,γ-二羰基-